Guidelines for Authors
www.karger.com/phg_guidelines
 Introduction
Submission
Conditions
Types of Papers
Arrangement
Color Illustrations
Nomenclature, Symbols, Abbreviations and Further Suggestions
References
Digital Object Identifier (DOI)
Author's ChoiceTM, NIH-Funded Research, Self-Archiving
Proofs
Reprints
Introduction
'Public Health Genomics' is the first peer-reviewed international journal to focus on the
translation of genome-based knowledge and technologies into public policy, disease prevention and
the improvement of population health. It is a multidisciplinary bi-monthly forum containing conceptual
and original research articles, editorials, reviews, short communications, country reports, case studies,
viewpoints, news and various other features about the nature of public health genomics and related concepts.
'Public Health Genomics' is unique and broad in scope combining theoretical and empirical work from a range
of disciplines, notably molecular and medical sciences, public health, humanities and social sciences. This
includes legal, ethical, social and economic issues, epidemiology, biostatistics, health promotion and
prevention, health information management, management of health innovations, infectious disease surveillance,
environmental and lifestyle factors, vaccination, population genomics, screening, biobanking, biotechnology,
health services research and health care systems.
Submission
Only original papers written in English are considered and should be submitted online:
Should you experience problems with your submission, please contact:
phgjournal@mcgill.ca
Editorial Office 'Public Health Genomics'
Centre of Genomics and Policy
Faculty of Medicine
Dept. of Human Genetics
McGill University
740 Dr. Penfield Avenue, 5th Floor
Montrééal, QC H3A 1A4
Canada
Fax +1 514 398 8954
Conditions
'Public Health Genomics' publishes papers reporting on original investigations or implementations of practices or policies in the field of public health genomics.
All manuscripts are subject to editorial review. Names, postal and e-mail addresses of two experts in the appropriate area of research should accompany each manuscript. Selected scientist(s) will be invited to act as referee(s). Please note that referees suggested should not be from the same institution as the author. Manuscripts must be accompanied by a covering letter indicating the section for which the paper is intended.
Submission of an article for publication implies the transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of 'Public Health Genomics' and may not be reproduced by any means, in whole or in part, without the written consent of the publisher.
It is the author's responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.
Types of Papers
'Public Health Genomics' consists of the following sections:
Original Papers
Reviews
Country Reports
Short Communications
Policy Statements
Original Papers are full-length research papers that will be considered for the journal. Articles cover topics relevant to public health genomics. The maximum word length should be between 4,000-6,000 words. The abstract should not exceed 250 words.
Reviews are overviews or syntheses of topics of current interest in public health genomics. Reviews may be invited by the Editors but we welcome unsolicited reviews (max. 6,000 words). In the latter instance, we ask the author to send the Associate Editor (susan.elizabeth.wallace@umontreal.ca) a short outline first (300-400 words) to ensure that a review on a similar subject has not already been commissioned. All reviews will be subjected to normal peer review procedures. The abstract should not exceed 250 words.
Country reports give an overview of public health genomics in a particular country, or part of a country. Papers should follow the following format:
- Introduction providing background information on the country, for example:
· data on the country's geography, population size, political system,
official language(s) and health care systems;
· population history (e.g., founders, migrants, bottlenecks, etc.);
· present population structures and substructures, including (genetic)
communities and their reproductive characteristics (e.g., consanguinity);
· general public health programs (e.g., vaccination, fluoridation)
- Detailed discussion of the current status of public health genomics-related programs and/or services available in the country, for example:
· genetic screening programs;
· genetic diagnosis and counselling services;
· patient, family, and/or community support services or programs.
- Discussion of what national practices/requirements are contributing to the integration of public health genomics in the country, for example:
· health technology assessment
· national/regional health observatories
· biobanking initiatives
· national legislation/regulations/guidance
· education programs
- Review of unmet needs, including existing barriers and how they could be overcome.
The text should not exceed 3,500 words. The number of tables and/or figures should not exceed five, and the number of references should be 50 or less. Suggested title: Country Name: Public Health Genomics. The abstract should not exceed 250 words.
Short Communications may reflect viewpoints of topical interest and will usually appear in print within 3 to 5 months. The maximum length should be between 1,600 and 2,000 words.
Policy Statements are short papers with relevance to policy making in the field of public health genomics. They include, but are not limited to, best practise examples, policy recommendations, and policy briefs, as well as guidelines on the assessment, provision and use of genome-based knowledge and technologies.
Arrangement
Title page: The first page of each paper should indicate the title, the authors’ names, the institute where the work was conducted, and a short title for use as running head.
NB: Authors wishing to preserve the phonetic meaning of diacritics (PubMed reduces diacritics to their root characters) must spell their names accordingly when submitting manuscripts (e.g. Müller should be Mueller).
Full address: The exact postal address of the corresponding author complete with postal code must be given at the bottom of the title page. Please also supply phone and fax numbers, as well as e-mail address.
Key words: For indexing purposes, a list of 3–10 key words in English is essential.
Abstract: Each paper needs an abstract of up to 200 words. It should contain the following information:
Background/Aims/Objective(s), Methods, Results, Conclusion(s).
Footnotes: Avoid footnotes. When essential, they are numbered consecutively and typed at the foot of the appropriate page.
Tables and illustrations: Tables and illustrations (both numbered in Arabic numerals) should be prepared on separate pages.
Tables require a heading and figures a legend, also prepared on a separate page. Due to technical reasons, figures with a screen
background should not be submitted. When possible, group several illustrations in one block for reproduction (max. size 180 x
223 mm) or provide crop marks. Each illustration must be labelled with its number and the first author's
name. B/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800-1,200 dpi.
Figure files must not be embedded in a document file but submitted separately (see Online Submission Instructions).
Color Illustrations
Online edition: Color illustrations are reproduced free of charge. In the print version, the illustrations are reproduced in black and white. Please avoid referring to the colors in the text and figure legends.
Print edition: Up to 6 color illustrations per page can be integrated within the text at CHF 760.00 per page.
Nomenclature, Abbreviations, Symbols and Further Suggestions
Human gene symbols: Only official gene symbols of the HUGO Gene
Nomenclature Committee (HGNC) are accepted. Authors must obtain or verify the official gene symbol of
the gene(s) mapped and indicate that they have done so in the manuscript submitted.
This can be accomplished for human genes by contacting
HUGO Gene Nomenclature Committee (HGNC)
European Bioinformatics Institute (EMBL-EBI)
Wellcome Trust Genome Campus
Hinxton, Cambridgeshire
CB10 1SA, UK
Fax +44 (0)1223 494 468
E-Mail hgnc@genenames.org
Website: www.genenames.org
Guidelines set forth by the HUGO Gene Nomenclature Committee are available at http://www.genenames.org/guidelines.html.
New symbols and names for genes can be requested electronically through the online gene symbol request form at http://www.genenames.org/cgi-bin/hgnc_request.pl.
Mouse: Guidelines set forth by the International Committee on Standardized Genetic
Nomenclature for Mice are available at www.informatics.jax.org/mgihome/nomen/table.shtml
Authors should use SI units and follow the guidelines for abbreviation and symbols of the IUPAC-IUB Joint Commission on Biochemical Nomenclature.
All nonstandard abbreviations used in the text should be defined immediately before the first such abbreviation. Abbreviations should not be over-used in the text and should never be used to begin a sentence.
Further suggestions: Single authors should avoid the use of the first person plural, and all authors should give careful thought to the use of tense. For example, information may flow more smoothly to the reader if the present tense is reserved for established phenomena and the past tense used for the results being reported. Similarly, the active voice is usually preferable to the passive voice. See also Do's and Don'ts.
References
In the text identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as 'unpublished data' and not be included in the reference list. The list of references should include only those publications which are cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text.
The surnames of the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors.
Abbreviate journal names according to the Index Medicus system. (Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med 1997;336:309–315. www.icmje.org)
|
Examples
(a) Papers published in periodicals:
Chatel J-M, Bernard H, Orson FM: Isolation and characterization of two complete Ara h 2 isoforms cDNA. Int Arch Allergy immunol 2003;131:14–18.
(b) Papers published only with DOI numbers:
Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858.
(c) Monographs:
Matthews DE, Farewell VT: Using and Understanding Medical Statistics, ed 3, revised. Basel, Karger, 1996.
(d) Edited books:
DuBois RN: cyclooxygenase-2 and colorectal cancer; in Dannenberg AJ, DuBois RN (eds): COX-2. Prog Exp Tum Res. Basel, karger, 2003, vol 37, pp 124–137.
|
Digital Object Identifier (DOI)
S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org
Author's ChoiceTM
Karger's Author's ChoiceTM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.Karger.com. The option is available for a one-time fee of USD 1,500.00, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice.
NIH-Funded Research
The U.S. National Institutes of Health (NIH) mandates under the NIH Public Access Policy that final, peer-reviewed manuscripts appear in its digital database within 12 months of the official publication date. As a service to authors, Karger submits the final version of your article on your behalf to PubMed Central. For those selecting our premium Author's ChoiceTM service, we will send your article immediately upon publishing, accelerating the accessibility of your work without the usual embargo. More details on NIH's Public Access Policy is available here.
Self-Archiving
Karger permits authors to archive their pre-prints (i.e. pre-refereeing) or post-prints (i.e. final draft post-refereeing) on their personal or institution's servers, provided the following conditions are met: Articles may not be used for commercial purposes, must be linked to the publisher's version, and must acknowledge the publisher's copyright. Authors selecting Karger's Author's ChoiceTM feature, however, are also permitted to archive the final, published version of their article, which includes copyediting and design improvements as well as citation links.
Proofs
Unless indicated otherwise, proofs are sent to the corresponding author and should be returned with the least possible delay. Alterations made in proofs, other than the correction of printer's errors, are charged to the author. No page proofs are supplied.
Reprints
Order forms and a price list for reprints are sent together with the proofs. Orders submitted after the issue is printed are subject to considerably higher prices.
|
|
|
| Search in this journal
|
|
|
|
Public Health Genomics
is the continuation of
Community Genetics
|
For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service. |
|
|
Online Manuscript Submission
Guidelines
